KLP Kapitalforvaltning’s Bio-Rad Laboratories Class A BIO Stock Holding History

KLP Kapitalforvaltning’s Portfolio BIO Stock Details BIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.2M	Hold	4,100	–	–	﹤0.01%	1020
2026 Q1	$1.14M	Buy	4,100 +120	+3%	+$34.6K	﹤0.01%	963
2025 Q4	$1.21M	Buy	3,980 +80	+2%	+$25K	﹤0.01%	936
2025 Q3	$1.09M	Sell	3,900 -200	-5%	-$54.4K	﹤0.01%	978
2025 Q2	$989K	Sell	4,100 -3,000	-42%	-$709K	﹤0.01%	996
2025 Q1	$1.73M	Hold	7,100	–	–	0.01%	686
2024 Q4	$2.33M	Buy	+7,100	New	+$2.41M	0.01%	621

Other funds holding BIO

First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

KLP Kapitalforvaltning's BIO Position: Q2 2026 in Review

KLP Kapitalforvaltning held its Bio-Rad Laboratories Class A (BIO) position steady in Q2 2026 at 4,100 shares worth $1.2M. The position accounts for ﹤0.01% of the portfolio, ranked #1020.

KLP Kapitalforvaltning first reported a position in BIO in Q4 2024 and has held it in 7 quarters since. The position peaked at $2.33M in Q4 2024. 400 funds tracked by Wall St. Rank hold BIO as of Q2 2026.

KLP Kapitalforvaltning held 4,100 shares of Bio-Rad Laboratories Class A worth $1.2M as of Q2 2026.
KLP Kapitalforvaltning left its Bio-Rad Laboratories Class A share count unchanged in Q2 2026.
Bio-Rad Laboratories Class A made up ﹤0.01% of KLP Kapitalforvaltning's portfolio in Q2 2026, its #1020 holding.
KLP Kapitalforvaltning first reported a position in Bio-Rad Laboratories Class A in Q4 2024 and has held it in 7 quarters since.
KLP Kapitalforvaltning's Bio-Rad Laboratories Class A position peaked at $2.33M in Q4 2024.
400 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2026.

Based on KLP Kapitalforvaltning's 13F filing for Q2 2026, filed 12 Aug 2026.